Connect with us

Hi, what are you looking for?

Friday, Dec 9, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Entourage launches medical pot marketplace focused on craft producers

With Syndicate, patients without insurance can access a catalogue of cannabis products, formats and brands at a competitive price

Entourage launches medical pot marketplace focusing on craft producers
Photo by Washarapol D BinYo Jundang via Pexels

Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) has launched the first medical marketplace focusing on craft producers.

On Tuesday, the Toronto-based company announced the launch of its marketplace Syndicate, which will be showcasing craft cannabis products sourced from in-house and third-party micro-producers.

The company said Syndicate complements the company’s Starseed Medicinal which provides medical pot to people with insurance benefits coverage. With Syndicate, patients without insurance can access a catalogue of cannabis products, formats and brands at a competitive price.

The marketplace will carry products from Greenseal Cannabis, Sitka Micro, Premium 5 and QWest Cannabis as well as a collective of micro-cultivators looking to distribute small-batch brands into the medical market.

“Launching Syndicate as a supplementary medical marketplace has been a long-time passion project for many of us at Entourage because it reinforces our commitment to providing optimal patient care with access to locally produced, quality cannabis products within a framework of affordability,” Entourage marketing director Nikki Thomas said.

“Additionally, in supporting craft producers with a medical outlet to share their unique offerings with our patients, we are taking our medical business to the next level.”

“Our Syndicate clients will have the same patient-centric services currently offered to our Starseed clients – all rooted in innovation, technology and education. Empowering our patients with a seamless online process and access to world-class customer service provides for a safe and responsible entry-point,” Thomas added.

Read more: Entourage Health partners with HelloMD to expand resources to patients

Read more: Entourage increases revenue 20% to $12.4M in Q1

“The original purpose for launching our company in 2013 harkens back to our deep-seeded belief that medical cannabis as a wellness option should be made available to all eligible Canadians and we are proud to be partnering with these micro-cultivators and licensed producers who share in this mission,” Entourage CEO George Scorsis said.

“With Syndicate, we are returning to our roots with access to medical cannabis at the heart of our purpose. We continue to advocate for cannabis medicine to be an insured benefit, but we know the reality is that not all our clients have access and this channel is dedicated to those patients.”

Entourage Health Corp. owns Entourage Brands Corp. –formerly WeedMD RX Inc.– and CannTx Life Sciences Inc. It owns and operates a 158-acre hybrid greenhouse located in Strathroy, Ontario and a fully licensed 26,000 square feet processing facility in Aylmer.


Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


New cannabinoid soft gel varieties from Irwin to be made available throughout Canada in the near future


Starseed Medicinal services' patient base grew over 50 per cent since 2019


Cannabis beverages continue to gain popularity and approval in Canada, according to industry analysts


Adjusted EBITDA went to a negative $9.3 million from a positive $7.7 million in the last year